img

Global Biopharmaceutical CMO Services Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biopharmaceutical CMO Services Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Biopharmaceutical CMO Services market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biopharmaceutical CMO Services market research.
Key companies engaged in the Biopharmaceutical CMO Services industry include Lonza, Boehringer Ingelheim, AGC Biologics, Rentschler Biotechnologie, JRS Pharma, Catalent, Biomeva, Samsung BioLogics and AbbVie, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Biopharmaceutical CMO Services were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Biopharmaceutical CMO Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceutical CMO Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Lonza
Boehringer Ingelheim
AGC Biologics
Rentschler Biotechnologie
JRS Pharma
Catalent
Biomeva
Samsung BioLogics
AbbVie
Binex
WuXi Biologics
PRA Health Sciences
ProBioGen
KBI Biopharma
Segment by Type
Biologics Manufacturing
Biosimilars Manufacturing
Others

Segment by Application


Clinical Manufacturing
Commercial Manufacturing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biopharmaceutical CMO Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO Services Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Biologics Manufacturing
1.2.3 Biosimilars Manufacturing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO Services Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Clinical Manufacturing
1.3.3 Commercial Manufacturing
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO Services Market Perspective (2018-2034)
2.2 Biopharmaceutical CMO Services Growth Trends by Region
2.2.1 Global Biopharmaceutical CMO Services Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Biopharmaceutical CMO Services Historic Market Size by Region (2018-2023)
2.2.3 Biopharmaceutical CMO Services Forecasted Market Size by Region (2024-2034)
2.3 Biopharmaceutical CMO Services Market Dynamics
2.3.1 Biopharmaceutical CMO Services Industry Trends
2.3.2 Biopharmaceutical CMO Services Market Drivers
2.3.3 Biopharmaceutical CMO Services Market Challenges
2.3.4 Biopharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO Services Players by Revenue (2018-2023)
3.1.2 Global Biopharmaceutical CMO Services Revenue Market Share by Players (2018-2023)
3.2 Global Biopharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical CMO Services Revenue
3.4 Global Biopharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO Services Revenue in 2024
3.5 Biopharmaceutical CMO Services Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical CMO Services Product Solution and Service
3.7 Date of Enter into Biopharmaceutical CMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO Services Breakdown Data by Type
4.1 Global Biopharmaceutical CMO Services Historic Market Size by Type (2018-2023)
4.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2024-2034)
5 Biopharmaceutical CMO Services Breakdown Data by Application
5.1 Global Biopharmaceutical CMO Services Historic Market Size by Application (2018-2023)
5.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Biopharmaceutical CMO Services Market Size (2018-2034)
6.2 North America Biopharmaceutical CMO Services Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Biopharmaceutical CMO Services Market Size by Country (2018-2023)
6.4 North America Biopharmaceutical CMO Services Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO Services Market Size (2018-2034)
7.2 Europe Biopharmaceutical CMO Services Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Biopharmaceutical CMO Services Market Size by Country (2018-2023)
7.4 Europe Biopharmaceutical CMO Services Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO Services Market Size (2018-2034)
8.2 Asia-Pacific Biopharmaceutical CMO Services Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO Services Market Size (2018-2034)
9.2 Latin America Biopharmaceutical CMO Services Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Biopharmaceutical CMO Services Market Size by Country (2018-2023)
9.4 Latin America Biopharmaceutical CMO Services Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO Services Market Size (2018-2034)
10.2 Middle East & Africa Biopharmaceutical CMO Services Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Biopharmaceutical CMO Services Introduction
11.1.4 Lonza Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.1.5 Lonza Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Biopharmaceutical CMO Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 AGC Biologics
11.3.1 AGC Biologics Company Detail
11.3.2 AGC Biologics Business Overview
11.3.3 AGC Biologics Biopharmaceutical CMO Services Introduction
11.3.4 AGC Biologics Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.3.5 AGC Biologics Recent Development
11.4 Rentschler Biotechnologie
11.4.1 Rentschler Biotechnologie Company Detail
11.4.2 Rentschler Biotechnologie Business Overview
11.4.3 Rentschler Biotechnologie Biopharmaceutical CMO Services Introduction
11.4.4 Rentschler Biotechnologie Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.4.5 Rentschler Biotechnologie Recent Development
11.5 JRS Pharma
11.5.1 JRS Pharma Company Detail
11.5.2 JRS Pharma Business Overview
11.5.3 JRS Pharma Biopharmaceutical CMO Services Introduction
11.5.4 JRS Pharma Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.5.5 JRS Pharma Recent Development
11.6 Catalent
11.6.1 Catalent Company Detail
11.6.2 Catalent Business Overview
11.6.3 Catalent Biopharmaceutical CMO Services Introduction
11.6.4 Catalent Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.6.5 Catalent Recent Development
11.7 Biomeva
11.7.1 Biomeva Company Detail
11.7.2 Biomeva Business Overview
11.7.3 Biomeva Biopharmaceutical CMO Services Introduction
11.7.4 Biomeva Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.7.5 Biomeva Recent Development
11.8 Samsung BioLogics
11.8.1 Samsung BioLogics Company Detail
11.8.2 Samsung BioLogics Business Overview
11.8.3 Samsung BioLogics Biopharmaceutical CMO Services Introduction
11.8.4 Samsung BioLogics Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.8.5 Samsung BioLogics Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Detail
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Biopharmaceutical CMO Services Introduction
11.9.4 AbbVie Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.9.5 AbbVie Recent Development
11.10 Binex
11.10.1 Binex Company Detail
11.10.2 Binex Business Overview
11.10.3 Binex Biopharmaceutical CMO Services Introduction
11.10.4 Binex Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.10.5 Binex Recent Development
11.11 WuXi Biologics
11.11.1 WuXi Biologics Company Detail
11.11.2 WuXi Biologics Business Overview
11.11.3 WuXi Biologics Biopharmaceutical CMO Services Introduction
11.11.4 WuXi Biologics Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.11.5 WuXi Biologics Recent Development
11.12 PRA Health Sciences
11.12.1 PRA Health Sciences Company Detail
11.12.2 PRA Health Sciences Business Overview
11.12.3 PRA Health Sciences Biopharmaceutical CMO Services Introduction
11.12.4 PRA Health Sciences Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.12.5 PRA Health Sciences Recent Development
11.13 ProBioGen
11.13.1 ProBioGen Company Detail
11.13.2 ProBioGen Business Overview
11.13.3 ProBioGen Biopharmaceutical CMO Services Introduction
11.13.4 ProBioGen Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.13.5 ProBioGen Recent Development
11.14 KBI Biopharma
11.14.1 KBI Biopharma Company Detail
11.14.2 KBI Biopharma Business Overview
11.14.3 KBI Biopharma Biopharmaceutical CMO Services Introduction
11.14.4 KBI Biopharma Revenue in Biopharmaceutical CMO Services Business (2018-2023)
11.14.5 KBI Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biopharmaceutical CMO Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Biologics Manufacturing
Table 3. Key Players of Biosimilars Manufacturing
Table 4. Key Players of Others
Table 5. Global Biopharmaceutical CMO Services Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Biopharmaceutical CMO Services Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Biopharmaceutical CMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Biopharmaceutical CMO Services Market Share by Region (2018-2023)
Table 9. Global Biopharmaceutical CMO Services Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Biopharmaceutical CMO Services Market Share by Region (2024-2034)
Table 11. Biopharmaceutical CMO Services Market Trends
Table 12. Biopharmaceutical CMO Services Market Drivers
Table 13. Biopharmaceutical CMO Services Market Challenges
Table 14. Biopharmaceutical CMO Services Market Restraints
Table 15. Global Biopharmaceutical CMO Services Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Biopharmaceutical CMO Services Market Share by Players (2018-2023)
Table 17. Global Top Biopharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2024)
Table 18. Ranking of Global Top Biopharmaceutical CMO Services Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Biopharmaceutical CMO Services Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biopharmaceutical CMO Services Product Solution and Service
Table 22. Date of Enter into Biopharmaceutical CMO Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biopharmaceutical CMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2018-2023)
Table 26. Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Table 28. Global Biopharmaceutical CMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2018-2023)
Table 30. Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Table 32. North America Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Biopharmaceutical CMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Biopharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Biopharmaceutical CMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Biopharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Biopharmaceutical CMO Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Biopharmaceutical CMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Biopharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 47. Lonza Company Detail
Table 48. Lonza Business Overview
Table 49. Lonza Biopharmaceutical CMO Services Product
Table 50. Lonza Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 51. Lonza Recent Development
Table 52. Boehringer Ingelheim Company Detail
Table 53. Boehringer Ingelheim Business Overview
Table 54. Boehringer Ingelheim Biopharmaceutical CMO Services Product
Table 55. Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 56. Boehringer Ingelheim Recent Development
Table 57. AGC Biologics Company Detail
Table 58. AGC Biologics Business Overview
Table 59. AGC Biologics Biopharmaceutical CMO Services Product
Table 60. AGC Biologics Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 61. AGC Biologics Recent Development
Table 62. Rentschler Biotechnologie Company Detail
Table 63. Rentschler Biotechnologie Business Overview
Table 64. Rentschler Biotechnologie Biopharmaceutical CMO Services Product
Table 65. Rentschler Biotechnologie Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 66. Rentschler Biotechnologie Recent Development
Table 67. JRS Pharma Company Detail
Table 68. JRS Pharma Business Overview
Table 69. JRS Pharma Biopharmaceutical CMO Services Product
Table 70. JRS Pharma Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 71. JRS Pharma Recent Development
Table 72. Catalent Company Detail
Table 73. Catalent Business Overview
Table 74. Catalent Biopharmaceutical CMO Services Product
Table 75. Catalent Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 76. Catalent Recent Development
Table 77. Biomeva Company Detail
Table 78. Biomeva Business Overview
Table 79. Biomeva Biopharmaceutical CMO Services Product
Table 80. Biomeva Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 81. Biomeva Recent Development
Table 82. Samsung BioLogics Company Detail
Table 83. Samsung BioLogics Business Overview
Table 84. Samsung BioLogics Biopharmaceutical CMO Services Product
Table 85. Samsung BioLogics Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 86. Samsung BioLogics Recent Development
Table 87. AbbVie Company Detail
Table 88. AbbVie Business Overview
Table 89. AbbVie Biopharmaceutical CMO Services Product
Table 90. AbbVie Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 91. AbbVie Recent Development
Table 92. Binex Company Detail
Table 93. Binex Business Overview
Table 94. Binex Biopharmaceutical CMO Services Product
Table 95. Binex Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 96. Binex Recent Development
Table 97. WuXi Biologics Company Detail
Table 98. WuXi Biologics Business Overview
Table 99. WuXi Biologics Biopharmaceutical CMO Services Product
Table 100. WuXi Biologics Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 101. WuXi Biologics Recent Development
Table 102. PRA Health Sciences Company Detail
Table 103. PRA Health Sciences Business Overview
Table 104. PRA Health Sciences Biopharmaceutical CMO Services Product
Table 105. PRA Health Sciences Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 106. PRA Health Sciences Recent Development
Table 107. ProBioGen Company Detail
Table 108. ProBioGen Business Overview
Table 109. ProBioGen Biopharmaceutical CMO Services Product
Table 110. ProBioGen Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 111. ProBioGen Recent Development
Table 112. KBI Biopharma Company Detail
Table 113. KBI Biopharma Business Overview
Table 114. KBI Biopharma Biopharmaceutical CMO Services Product
Table 115. KBI Biopharma Revenue in Biopharmaceutical CMO Services Business (2018-2023) & (US$ Million)
Table 116. KBI Biopharma Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical CMO Services Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Biopharmaceutical CMO Services Market Share by Type: 2024 VS 2034
Figure 3. Biologics Manufacturing Features
Figure 4. Biosimilars Manufacturing Features
Figure 5. Others Features
Figure 6. Global Biopharmaceutical CMO Services Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 7. Global Biopharmaceutical CMO Services Market Share by Application: 2024 VS 2034
Figure 8. Clinical Manufacturing Case Studies
Figure 9. Commercial Manufacturing Case Studies
Figure 10. Others Case Studies
Figure 11. Biopharmaceutical CMO Services Report Years Considered
Figure 12. Global Biopharmaceutical CMO Services Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Biopharmaceutical CMO Services Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Biopharmaceutical CMO Services Market Share by Region: 2024 VS 2034
Figure 15. Global Biopharmaceutical CMO Services Market Share by Players in 2024
Figure 16. Global Top Biopharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO Services Revenue in 2024
Figure 18. North America Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Biopharmaceutical CMO Services Market Share by Country (2018-2034)
Figure 20. United States Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Biopharmaceutical CMO Services Market Share by Country (2018-2034)
Figure 24. Germany Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Biopharmaceutical CMO Services Market Share by Region (2018-2034)
Figure 32. China Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Biopharmaceutical CMO Services Market Share by Country (2018-2034)
Figure 40. Mexico Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Biopharmaceutical CMO Services Market Share by Country (2018-2034)
Figure 44. Turkey Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Biopharmaceutical CMO Services Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Lonza Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 48. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 49. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 50. JRS Pharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 51. Catalent Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 52. Biomeva Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 53. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 54. AbbVie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 55. Binex Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 56. WuXi Biologics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 57. PRA Health Sciences Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 58. ProBioGen Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 59. KBI Biopharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed